# Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants

> **NCT02812342** · PHASE2 · COMPLETED · sponsor: **Yale University** · enrollment: 10 (actual)

## Conditions studied

- Alopecia Areata
- Alopecia Totalis
- Alopecia Universalis

## Interventions

- **DRUG:** Tofacitinib ointment

## Key facts

- **NCT ID:** NCT02812342
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2018-07
- **Final completion:** 2018-12
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2019-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02812342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02812342, "Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02812342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*